CHINA ASSET MANAGEMENT (HK) CHINAAMC HANG SENG BIOTECH ETF HKDCHINA ASSET MANAGEMENT (HK) CHINAAMC HANG SENG BIOTECH ETF HKDCHINA ASSET MANAGEMENT (HK) CHINAAMC HANG SENG BIOTECH ETF HKD

CHINA ASSET MANAGEMENT (HK) CHINAAMC HANG SENG BIOTECH ETF HKD

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪502.44 M‬HKD
Fund flows (1Y)
‪−456.68 M‬HKD
Dividend yield (indicated)
0.46%
Discount/Premium to NAV
0.2%
Shares outstanding
‪39.60 M‬
Expense ratio
0.71%

About CHINA ASSET MANAGEMENT (HK) CHINAAMC HANG SENG BIOTECH ETF HKD


Brand
ChinaAMC
Inception date
Mar 18, 2021
Index tracked
Hang Seng Biotech Index - HKD - Benchmark TR Net
Replication method
Physical
Management style
Passive
Dividend treatment
Distributes
Primary advisor
China Asset Management (Hong Kong) Ltd.
ISIN
HK0000711199
The investment objective of the Sub-Fund is to provide investment results that, before fees and expenses, closely correspond to the performance of the Hang Seng Hong Kong-Listed Biotech Index.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Pharma, biotech & life sciences
Strategy
Vanilla
Geography
Hong Kong
Weighting scheme
Market cap
Selection criteria
Market cap
What's in the fund
Exposure type
StocksBonds, Cash & Other
Health Technology
Stock breakdown by region
9%90%
Top 10 holdings
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Broaden your horizons with more funds linked to 3069 via country, focus, and more.

Frequently Asked Questions


An exchange-traded fund (ETF) is a collection of assets (stocks, bonds, commodities, etc.) that track an underlying index and can be bought on an exchange like individual stocks.
3069 trades at 12.94 HKD today, its price has risen 1.41% in the past 24 hours. Track more dynamics on 3069 price chart.
3069 net asset value is 12.91 today — it's risen 11.34% over the past month. NAV represents the total value of the fund's assets less liabilities and serves as a gauge of the fund's performance.
3069 assets under management is ‪502.44 M‬ HKD. AUM is an important metric as it reflects the fund's size and can serve as a gauge of how successful the fund is in attracting investors, which, in its turn, can influence decision-making.
3069 price has risen by 13.01% over the last month, and its yearly performance shows a 58.19% increase. See more dynamics on 3069 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 11.34% over the last month, showed a 22.86% increase in three-month performance and has increased by 60.57% in a year.
3069 fund flows account for ‪−456.68 M‬ HKD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Since ETFs work like an individual stock, they can be bought and sold on exchanges (e.g. NASDAQ, NYSE, EURONEXT). As it happens with stocks, you need to select a brokerage to access trading. Explore our list of available brokers to find the one to help execute your strategies. Don't forget to do your research before getting to trading. Explore ETFs metrics in our ETF screener to find a reliable opportunity.
3069 invests in stocks. See more details in our Analysis section.
3069 expense ratio is 0.71%. It's an important metric for helping traders understand the fund's operating costs relative to assets and how expensive it would be to hold the fund.
No, 3069 isn't leveraged, meaning it doesn't use borrowings or financial derivatives to magnify the performance of the underlying assets or index it follows.
In some ways, ETFs are safe investments, but in a broader sense, they're not safer than any other asset, so it's crucial to analyze a fund before investing. But if your research gives a vague answer, you can always refer to technical analysis.
Today, 3069 technical analysis shows the buy rating and its 1-week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1-month rating 3069 shows the buy signal. See more of 3069 technicals for a more comprehensive analysis.
Yes, 3069 pays dividends to its holders with the dividend yield of 0.46%.
3069 trades at a premium (0.21%).
Premium/discount to NAV expresses the difference between the ETF’s price and its NAV value. A positive percentage indicates a premium, meaning the ETF trades at a higher price than the calculated NAV. Conversely, a negative percentage indicates a discount, suggesting the ETF trades at a lower price than NAV.
3069 shares are issued by CITIC Securities Co., Ltd.
3069 follows the Hang Seng Biotech Index - HKD - Benchmark TR Net. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
The fund started trading on Mar 18, 2021.
The fund's management style is passive, meaning it's aiming to replicate the performance of the underlying index by holding assets in the same proportions as the index. The goal is to match the index's returns.